Similar companies
Are Members of Congress Buying or Selling Genprex?
No members of Congress have reported trading Genprex (GNPX) stock in the past 90 days. The history below covers the past two years.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the GNPX AI Score. For corporate insider activity, see GNPX insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
Which Congress Members Are Trading Genprex?
| Member of Congress | Activity | Trades | Last Trade |
|---|---|---|---|
| Tim Moore | Bought $24,000 | 3 | Feb 5, 2026 |
GNPX Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Tim Moore | Feb 5, 2026 | Buy | $1K – $15K |
| Tim Moore | Dec 18, 2025 | Buy | $1K – $15K |
| Tim Moore | Nov 7, 2025 | Buy | $1K – $15K |
Frequently Asked Questions: Genprex Congress Trading
No members of Congress have reported buying or selling GNPX stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Tim Moore bought Genprex (GNPX) stock most recently, on February 5, 2026.
The estimated net value of congressional trades in Genprex over the past 2 years is positive, at $24,000, meaning members of Congress have on balance bought more than they have sold.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
